Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering.
Increased oxidative stress is a major characteristic of hypercholesterolemia-induced atherosclerosis. The oxidative environment is mainly created by the production of reactive oxygen species, which are assumed to mediate vascular tissue injury. Oxidative DNA damage resulting from free radical attack remains, however, a poorly examined field in atherosclerosis. Male New Zealand White rabbits were fed a cholesterol-rich diet (0.3%) for 24 weeks. The induced atherosclerotic plaques showed elevated levels of the DNA damage marker 7,8-dihydro-8-oxoguanine (8-oxoG) as demonstrated by immunohistochemistry. 8-oxoG immunoreactivity was found predominantly in the superficial layer of the plaque containing numerous macrophage-derived foam cells but not in the media or in arteries of age-matched control animals. Alkaline single-cell gel electrophoresis revealed that the number of DNA strand breaks was significantly higher in the plaque as compared with control samples of normolipemic animals. These changes were associated with the upregulation of DNA repair enzymes (poly[ADP-ribose] polymerase-1, p53, phospho-p53 [phosphorylated at Ser392], and XRCC1 [x-ray repair cross-complementing 1]). DNA strand breaks normalized after 4 weeks of dietary lipid lowering. However, a significant reduction of 8-oxoG immunoreactivity was only observed after a prolonged period of lipid lowering (12 to 24 weeks). Repair pathways started to decline progressively when cholesterol-fed animals were placed on a normal diet. In conclusion, oxidative DNA damage and increased levels of DNA repair, both associated with diet-induced hypercholesterolemia, are strongly reduced during dietary lipid lowering. These findings may provide a better insight into the benefits of lipid-lowering therapy on plaque stabilization.
Martinet
W
W
Division of Pharmacology, University of Antwerp, Wilrijk, Belgium.
Knaapen
M W
MW
De Meyer
G R
GR
Herman
A G
AG
Kockx
M M
MM
D000818:Animals; D001011:Aorta / Q000378:metabolism / Q000473:pathology; D001161:Arteriosclerosis / Q000178:diet therapy* / Q000378:metabolism / Q000473:pathology; D015153:Blotting, Western; D002784:Cholesterol / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D020552:Comet Assay; D004247:DNA / Q000378:metabolism; D004249:DNA Damage / Q000187:drug effects*; D011088:DNA Ligases / Q000378:metabolism; D004260:DNA Repair / Q000187:drug effects*; D004036:Diet, Atherogenic; D004041:Dietary Fats / Q000378:metabolism / Q000494:pharmacology*; D004195:Disease Models, Animal; D007150:Immunohistochemistry; D008055:Lipids / Q000097:blood; D008297:Male; D018384:Oxidative Stress; D011817:Rabbits; D016896:Treatment Outcome
D004041:Dietary Fats; D008055:Lipids; D004247:DNA; D002784:Cholesterol; D011088:DNA Ligases